Allan Jonathan
Reporting owner on Forms 3, 4 and 5, CIK 1966716.
Allan Jonathan reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-02.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Stoke Therapeutics, Inc. CIK 1623526 | officer (GENERAL COUNSEL & CORP SEC) | 1 | 2026-10-02 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Stoke Therapeutics, Inc. Common Stock | 2026-10-02 | S sold | -627 | $26.33 | 20,598 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001966716-26-000014 | Stoke Therapeutics, Inc. | 2026-10-02 |